Literature DB >> 10350645

Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice.

G Y Yang1, C Gong, Z Qin, X H Liu, A Lorris Betz.   

Abstract

Alteration of blood-brain barrier (BBB) function occurs in both permanent and temporary cerebral ischemia. Studies in vivo and in vitro have shown that tumor necrosis factor-alpha (TNFalpha) is involved in changes of BBB permeability. However, the relationship between TNFalpha expression and BBB disruption during reperfusion is unclear. The aim of this study is to find the cell source of TNFalpha and to determine the relationship between TNFalpha expression and BBB disruption following temporary focal cerebral ischemia in mice. Adult CD-1 mice received 1 h middle cerebral artery occlusion (MCAO) followed by 2 h, 6 h, 12 h, 24 h, and 48 h of reperfusion. MCAO was achieved using an intraluminal suture technique and reperfusion was performed by the suture withdrawal. Neutralizing monoclonal anti-mouse TNFalpha antibody was administrated intraventricularly immediately after reperfusion. TNFalpha expression was determined by double labeling immunohistochemistry. BBB permeability was determined by albumin immunostaining. TNFalpha immunoreactivity (IR) was observed in the ipsilateral hemisphere from 1 h MCAO with 2 h reperfusion. TNFalpha positive cells included neurons, astrocytes, and ependymal cells. BBB disruption was detected beginning at 6 h reperfusion but was not present at 2 h of reperfusion. The areas of BBB disruption were significantly enlarged at 12 h reperfusion and plateaued at 24 h to 48 h reperfusion. BBB disruptions were significantly attenuated in the anti-TNFalpha antibody treated mice (p<0.05). Our results demonstrate that TNFalpha IR existed in neurons, astrocytes, and ependymal cells during reperfusion. TNFalpha IR following temporary focal cerebral ischemia precedes increased BBB permeability. Treatment with TNFalpha antibody reduces BBB disruption, suggesting TNFalpha may be an important mediator in altering BBB permeability during reperfusion. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10350645     DOI: 10.1016/s0169-328x(99)00007-8

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  46 in total

1.  Specificity of Toll-Like Receptor 2 and Dectin-1 Signaling in CNS Macrophages.

Authors:  Deepak Kumar Vijaya Kumar; William A Eimer; Sreejith Ramakrishnan
Journal:  J Neurosci       Date:  2015-12-09       Impact factor: 6.167

Review 2.  Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.

Authors:  Zhongwu Liu; Michael Chopp
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

Review 3.  CNS drug delivery: opioid peptides and the blood-brain barrier.

Authors:  Ken A Witt; Thomas P Davis
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

4.  Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury.

Authors:  Fang Hua; Jing Ma; Tuanzhu Ha; Jim Kelley; David L Williams; Race L Kao; John H Kalbfleisch; I William Browder; Chuanfu Li
Journal:  J Neuroimmunol       Date:  2008-06-27       Impact factor: 3.478

Review 5.  Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure.

Authors:  Stephen F Rodrigues; D Neil Granger
Journal:  Cardiovasc Res       Date:  2010-03-17       Impact factor: 10.787

Review 6.  Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.

Authors:  Changjun Yang; Kimberly E Hawkins; Sylvain Doré; Eduardo Candelario-Jalil
Journal:  Am J Physiol Cell Physiol       Date:  2018-10-31       Impact factor: 4.249

Review 7.  Inflammatory cytokines in experimental and human stroke.

Authors:  Kate Lykke Lambertsen; Knut Biber; Bente Finsen
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-27       Impact factor: 6.200

Review 8.  Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets.

Authors:  Danielle N Doll; Taura L Barr; James W Simpkins
Journal:  Aging Dis       Date:  2014-10-01       Impact factor: 6.745

Review 9.  TAM receptor deficiency affects adult hippocampal neurogenesis.

Authors:  Rui Ji; Lingbin Meng; Qiutang Li; Qingxian Lu
Journal:  Metab Brain Dis       Date:  2014-12-10       Impact factor: 3.584

10.  Reduced blood brain barrier breakdown in P-selectin deficient mice following transient ischemic stroke: a future therapeutic target for treatment of stroke.

Authors:  Albert Y Jin; Ursula I Tuor; David Rushforth; Jaspreet Kaur; Robert N Muller; Jodie Lee Petterson; Sébastien Boutry; Philip A Barber
Journal:  BMC Neurosci       Date:  2010-02-02       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.